Answer
Promixin (colistimethate sodium) is licensed to manage chronic pulmonary infections due to Pseudomonas aeruginosa in adults and children with cystic fibrosis.
Sources for this answer
- Promixin 1 million International Units (IU) Powder for Nebuliser SolutionZambon UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 15Document updated
Sources checked